UNSPSC 51172423: Aspirin/citric acid/sodium bicarbonate

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class GA110. This VA Drug Class (GA110) classifies this compound as belonging to the group SODIUM BICARBONATE CONTAINING ANTACIDS.

UNSPSC 51172423 Aspirin/citric acid/sodium bicarbonate is a Commodity code that state and local procurement offices use to classify over-the-counter pain relief and antacid products, but recent activity shows the code capturing a much broader range of pharmaceutical and testing-related contracting. State and local buyers soliciting under or near this code span county corrections departments, state health and human services agencies, and cooperative purchasing alliances serving multiple states and jurisdictions. The actual work encompasses offender drug testing services with immunoassay and confirmatory testing protocols, state pharmacy benefit program initiatives involving direct manufacturer relationships, and multi-source generic pharmaceutical and OTC product distribution through established wholesaler networks.

Recent activity concentrates in Texas and Minnesota. Collin County Community Supervision and Corrections Department posted RFP 2026-327 on July 9, 2026, for offender specimen collection and drug testing services with a response due July 23, 2026 and an estimated contract value of $600,000 over two years with three optional one-year renewal periods. The Texas Health and Human Services Commission issued RFI HHS0017013 in late March 2026 to gather vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, functioning as preliminary market intelligence rather than a formal competitive solicitation. The Minnesota Department of Administration's Office of State Procurement, administering the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), posted RFP S1070000015802 on January 20, 2026, for generic multi-source pharmaceuticals and OTC products to serve participating state and local government facilities across Minnesota and Oregon, with proposals due March 26, 2026. The MMCAP contract requires vendors to work through three authorized wholesalers—AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC—and imposes a 3 percent administrative fee with performance penalties up to $1,500 per violation.